Computer-Facilitated 5A's for Smoking Cessation in Primary Care
調査の概要
詳細な説明
This project develops and tests a computer-facilitated 5A's (CF-5A's) model that administers the 5A's intervention to patients then prompts providers for reinforcing next steps. CF-5A's could efficiently and effectively promote smoking cessation while educating providers about cessation resources and appropriate follow-up. Based on the Technology Acceptance Model, clinically tailored strategies to promote CF-5A's implementation will be developed and tested to ensure the appropriate use and uptake of this new service delivery model. Development of the model, materials, and strategies will occur in years 1 and 2.
Baseline data collection occurs in year 2, followed by a randomized trial of CF- 5A's where the provider is the unit of randomization. Provider use of the 5A's will primarily be assessed with a brief phone call to the patient after the primary care visit has occurred.
Although focused on 5A's for smoking cessation, this study examines the underlying implementation science of computer-aided service delivery models with important implications for the integration of other substance use or behavioral health interventions in primary care. Implementation factors will be assessed using qualitative interviews and brief pre-post surveys.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
California
-
San Francisco、California、アメリカ、94110
- San Francisco General Hospital
-
San Francisco、California、アメリカ、94115
- UCSF Adult Primary Care Mt. Zion Clinic
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria: All primary care providers and clinic staff are eligible to participate. Patients must have
- a primary care appointment
- smoked a cigarette in past 7 days
- smoked at least 100 cigarettes in lifetime
- speak English or Spanish
- be cognitively able to use computer tablet
Exclusion Criteria:
- Moderate to severe cognitive impairment
- Does not speak English or Spanish
- acute intoxication on alcohol or illicit drugs
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：ヘルスサービス研究
- 割り当て：ランダム化
- 介入モデル：単一グループの割り当て
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Tablet Intervention
Primary care providers will be randomized into intervention or control conditions.
The patients of intervention providers will be given a computer tablet that provides 5A's for smoking cessation counseling.
Patients of control providers will not receive a tablet intervention.
|
|
|
介入なし：Control
Primary care providers will be randomized into intervention or control conditions.
The patients of intervention providers will be given a computer tablet that provides 5A's for smoking cessation counseling.
Patients of control providers will not receive a tablet intervention.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
5A's Fidelity
時間枠：Baseline assessment 2013-14; Intervention 2014-2015
|
Baseline and post-tablet intervention assessments of primary care provider adherence to 5A's protocol for smoking cessation.
Patients are called after their primary care appointment and asked a series of questions to determine if (and which of) the 5A's were used during that visit.
|
Baseline assessment 2013-14; Intervention 2014-2015
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Tablet Usage
時間枠：7/2014-7/2015
|
Intervention includes system strategies to improve usage of computer tablets in primary care waiting rooms.
Outcome = tablet saturation or proportion of patients given a tablet.
|
7/2014-7/2015
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Implementation Factors
時間枠：July 2013-2015
|
Qualitative interview data to assess the utility of the "Technology Acceptance Model" in explaining tablet and 5A's usage.
Variables assessed include perceived usefulness, social norms and influence, and facilitating conditions.
|
July 2013-2015
|
協力者と研究者
捜査官
- 主任研究者：Jason M Satterfield, PhD、University of California
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- 1R01DA034253-01 (米国 NIH グラント/契約)
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。